7IM2
Group deposition for crystallographic fragment screening of SARS-CoV-2 nucleocapsid protein (CTD) -- Crystal Structure of SARS-CoV-2 nucleocapsid protein (CTD) in complex with Z319545618 (Nprot-x0329)
Summary for 7IM2
| Entry DOI | 10.2210/pdb7im2/pdb |
| Group deposition | Group deposition for crystallographic fragment screening of SARS-CoV-2 nucleocapsid protein (CTD) (G_1002353) |
| Descriptor | Nucleoprotein, 3-[(2-methyl-1H-imidazol-1-yl)methyl]benzonitrile, DI(HYDROXYETHYL)ETHER, ... (7 entities in total) |
| Functional Keywords | diamond i04-1, pandda2, xchemexplorer, crystallographic fragment screening, sars-cov-2, nucleocapsid protein, n protein, viral protein |
| Biological source | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV, SARS-CoV-2) More |
| Total number of polymer chains | 1 |
| Total formula weight | 13595.78 |
| Authors | Aschenbrenner, J.C.,Luptak, J.,Balcomb, B.H.,Marples, P.G.,Bellini, D.,Yu, C.W.,Douangamath, A.,Dias, A.,Powell, A.,Fearon, D.,James, L.,von Delft, F. (deposition date: 2025-08-11, release date: 2026-08-26) |
| Primary citation | Luptak, J.,Aschenbrenner, J.C.,Balcomb, B.H.,Marples, P.G.,Bellini, D.,Yu, C.W.,Douangamath, A.,Dias, A.,Powell, A.,Fearon, D.,James, L.,von Delft, F. Group deposition for crystallographic fragment screening of SARS-CoV-2 nucleocapsid protein (CTD) To Be Published, |
| Experimental method | X-RAY DIFFRACTION (1.62 Å) |
Structure validation
Download full validation report






